诺思格: 第五届董事会第十三次会议决议公告

Core Viewpoint - The company, 诺思格 (Beijing) Pharmaceutical Technology Co., Ltd., has approved a series of proposals related to its 2025 Employee Stock Ownership Plan (ESOP) during its board meeting held on September 5, 2025, aiming to enhance employee engagement and company governance [1][2][3][4]. Group 1: Board Meeting Details - The fifth board meeting was held with all 9 directors present, ensuring compliance with relevant laws and the company's articles of association [1]. - The board approved the proposal for the 2025 Employee Stock Ownership Plan draft with unanimous support [2]. - The board also approved the management measures for the 2025 Employee Stock Ownership Plan, which will be submitted for shareholder approval [3]. Group 2: Shareholder Proposals - The board proposed to authorize itself to handle all matters related to the 2025 Employee Stock Ownership Plan, pending shareholder approval [4]. - A proposal was made to appoint a new independent director following the resignation of an existing director, with the nomination of 胡晓红 as a candidate [4][5]. - The board agreed to convene the second extraordinary general meeting of shareholders on September 23, 2025, to discuss these matters [5].